DAVID C. HOVDA - Corporate Board Profile

PRO DEX INC

Filing Date	Source Excerpt
2013-10-24	David C. Hovda (51), current director and nominee, has served as President, Chief Executive Officer and a member of the Board of Directors of Spinal Motion, Inc., a privately held medical device company. Mr. Hovda has been a director of our since January 2013. The table shows he is Chairman of Audit Committee, member of Compensation and Nominating and Governance committees. The 2013 Directors’ Compensation Plan shows he was granted options and earned $7,250 in fees and $22,749 in option awards, totaling $29,999.
2014-10-22	Our Board is currently composed of five members... David C. Hovda 52 Director C X ... Mr. Hovda has been a director of ours since January 2013... The following table details the cash retainers and fees, as well as equity compensation in the form of stock awards, paid to our non-employee directors during fiscal 2014: ... David C. Hovda $24,400 ...
2015-10-22	David C. Hovda (53), current director and nominee, has served as President, Chief Executive Officer and a member of the Board of Directors of Simplify Medical, Inc., a privately held medical device company that has developed a cervical artificial disc replacement optimized for MRI imaging, since 2013. Prior to his tenure with Simplify Medical, he was President, Chief Executive Officer and a member of the Board of Directors of SpinalMotion, Inc., a privately held medical device company that designed, developed and marketed artificial discs for use in the spine, from 2004 to 2013. Prior to joining Spinal Motion, he held leadership positions with Arthrocare, Inc. (Nasdaq: ARTC), a developer and manufacturer of surgical devices, instruments, and implants focused on enhancing surgical techniques and patient outcomes, serving as the Vice President/General Manager of its Spine Division from 1999 to 2004, and as the Managing Director of its ENT Division from 1997 to 1999. From 1992 to 1997, Mr. Hovda served in financial analysis and product management positions with Medtronic, Inc. (NYSE: MDT), a multi-national medical technology company, which culminated in his service as the European Business Manager of its Upper Airway Venture from 1995 to 1997. He holds more than 40 patents related to radio frequency ablation technology, specific clinical applications, and artificial disc replacement designs and implantation methods. Mr. Hovda served for five years with the United States Navy, achieving the rank of Lieutenant. He received a Bachelor of Science degree in Civil Engineering from Northwestern University and an M.B.A. from the Harvard Graduate School of Business Administration. Mr. Hovda has been a director of ours since January 2013. Mr. Hovda brings the following experience, qualifications, attributes and skills to our Board: Current senior-level management, operating and board experience based on more than 20 years of participation in the medical device industry, our primary target market, nine years of which are specifically with medical devices to treat disorders of the spine, a sector within the medical device industry that we believe represents potential for future revenue growth; Core management and leadership skills gained through experience overseeing and managing operations at the manager and chief executive officer levels, including experience in medical device intellectual property, product development, clinical testing and marketing; Experience in financial analysis, including operational restructuring, acquisition opportunities and market entry feasibility; and Independent of our management. 2013 Directors Compensation Plan The following table details the cash retainers and fees, as well as equity compensation in the form of stock awards, paid to our non-employee directors during fiscal 2015: Name Fees Paid in Cash($) Option Awards($) Total($) David C. Hovda $24,800 24,800 William J. Farrell III $1,400 1,400 Nicholas J. Swenson $2,000 2,000 Raymond E. Cabillot $2,000 2,000 The cash amount reported in this column represents amounts paid to directors during fiscal 2015 and in some cases includes a portion of fees earned in fiscal 2014.
2016-10-17	David C. Hovda (54), current director and nominee, has served as President, Chief Executive Officer and a member of the Board of Directors of Simplify Medical, Inc., a privately held medical device company that has developed a cervical artificial disc replacement optimized for MRI imaging, since 2013. Prior to his tenure with Simplify Medical, he was President, Chief Executive Officer and a member of the Board of Directors of SpinalMotion, Inc., a privately held medical device company that designed, developed and marketed artificial discs for use in the spine, from 2004 to 2013. Prior to joining Spinal Motion, he held leadership positions with Arthrocare, Inc. (Nasdaq: ARTC), a developer and manufacturer of surgical devices, instruments, and implants focused on enhancing surgical techniques and patient outcomes, serving as the Vice President/General Manager of its Spine Division from 1999 to 2004, and as the Managing Director of its ENT Division from 1997 to 1999. From 1992 to 1997, Mr. Hovda served in financial analysis and product management positions with Medtronic, Inc. (NYSE: MDT), a multi-national medical technology company, which culminated in his service as the European Business Manager of its Upper Airway Venture from 1995 to 1997. He holds more than 40 patents related to radio frequency ablation technology, specific clinical applications, and artificial disc replacement designs and implantation methods. Mr. Hovda served for five years with the United States Navy, achieving the rank of Lieutenant. He received a Bachelor of Science degree in Civil Engineering from Northwestern University and an M.B.A. from the Harvard Graduate School of Business Administration. Mr. Hovda has been a director of ours since January 2013.
2017-10-19	David C. Hovda 55 Director C X ...The following table details the cash retainers and fees, as well as equity compensation in the form of stock awards, earned by our non-employee directors during fiscal 2017: David C. Hovda $25,000 William J. Farrell III $18,000 Nicholas J. Swenson $18,000 Raymond E. Cabillot $18,000 ...The cash amount reported in this column represents amounts earned during fiscal 2017.
2018-10-05	David C. Hovda 56 Director Audit: C Compensation: X The following table details the cash fees, as well as equity compensation in the form of stock awards, earned by our non-employee directors during fiscal 2018: Name: David C. Hovda Fees Paid in Cash: $25,000 Option Awards: $0 Total: $25,000
2019-10-07	David C. Hovda (57), current director and nominee, has served as President, Chief Executive Officer and a member of the Board of Directors of Simplify Medical, Inc., a privately held medical device company ... Mr. Hovda has been a director of ours since January 2013. The following table details the cash fees, as well as equity compensation in the form of stock awards, earned by our non-employee directors during fiscal 2019: Name Fees Paid in Cash ($) Option Awards ($) Total ($) David C. Hovda $25,000 $0 $25,000 Our Board has an Audit Committee that consists of three Board members, Messrs. Hovda (Chairman), Cabillot and Swenson. Our Board has a Compensation Committee that consists of three Board members, Messrs. Swenson (Chairman), Cabillot and Farrell.
2020-10-06	David C. Hovda 58 Director C X ...The following table details the cash fees earned by our non-employee directors during fiscal 2020. No stock options or other compensation was issued or paid to our non-employee directors during fiscal 2020. David C. Hovda $ 25,000 Raymond E. Cabillot $ 18,000 William J. Farrell III $ 18,000 Katrina M.K. Philp $ 9,000 Nicholas J. Swenson $ 18,000
2021-10-05	David C. Hovda 59 Director Audit: C The following table details the fees earned by our non-employee directors during fiscal 2021. David C. Hovda $18,000 $347,080 $372,080 Raymond E. Cabillot $18,000 $347,080 $365,080 William J. Farrell III $18,000 $347,080 $365,080 Katrina M.K. Philp $18,000 $347,080 $365,080 Nicholas J. Swenson $18,000 $347,080 $365,080
2022-10-03	David C. Hovda 60 Director Audit: C The following table details the fees earned by our non-employee directors during fiscal 2022. David C. Hovda $25,000
2023-10-27	David C. Hovda 61 Director Audit: C The following table details the fees earned by our non-employee directors during fiscal 2023. David C. Hovda $25,000 $25,000
2024-10-08	David C. Hovda 62 Director Audit C. The following table details the fees earned by our non-employee directors during fiscal 2024. David C. Hovda $25,000 Total $25,000.